{"entity":{"type":"insider","cik":"0001579887","url":"/insider/0001579887","json_url":"/insider/0001579887.json","name":"Backenroth Samuel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":5,"first":"2015-02-10","last":"2020-05-04","span_basis":"filed_date"},"name_variants":[{"name":"Backenroth Samuel","source":"filing","n_filings":5,"first_seen":"2015-02-10","last_seen":"2020-05-04"}],"transactions":[{"id":2862608,"accession":"0001104659-20-056066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-056066","line_url":"/filing/0001104659-20-056066#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001579887","owner_name":"Backenroth Samuel","owner_display_name":"Backenroth Samuel","owner_url":"/insider/0001579887","role":"Officer (CFO, Treasurer & Secretary)","role_mark":"O","role_mark_label":"Officer (CFO, Treasurer & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Treasurer & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":11630.0,"shares_owned_after_display":"11,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-30","filed_date":"2020-05-04","scope":"insider"},{"id":4637349,"accession":"0001387131-17-002049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-17-002049","line_url":"/filing/0001387131-17-002049#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001579887","owner_name":"Backenroth Samuel","owner_display_name":"Backenroth Samuel","owner_url":"/insider/0001579887","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71429.0,"shares_display":"71,429","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":50000.3,"total_display":"50,000.30","total_whole":"50,000","shares_owned_after":212596.0,"shares_owned_after_display":"212,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-10","filed_date":"2017-04-13","scope":"insider"},{"id":2613132,"accession":"0001387131-16-005871","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001387131-16-005871","line_url":"/filing/0001387131-16-005871","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001579887","owner_name":"Backenroth Samuel","owner_display_name":"Backenroth Samuel","owner_url":"/insider/0001579887","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2468.0,"shares_display":"2,468","price_per_share":2.835267423014587,"price_display":"2.84","price_state":"stated","total_value":6997.44,"total_display":"6,997.44","total_whole":"6,997","shares_owned_after":140967.0,"shares_owned_after_display":"140,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-20","filed_date":"2016-06-21","scope":"insider","n_lines":5},{"id":2806652,"accession":"0001387131-16-005678","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001387131-16-005678","line_url":"/filing/0001387131-16-005678","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001579887","owner_name":"Backenroth Samuel","owner_display_name":"Backenroth Samuel","owner_url":"/insider/0001579887","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.170402,"price_display":"3.17","price_state":"stated","total_value":7926.005,"total_display":"7,926.00","total_whole":"7,926","shares_owned_after":137789.0,"shares_owned_after_display":"137,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider","n_lines":14},{"id":8814537,"accession":"0001387131-15-000444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-15-000444","line_url":"/filing/0001387131-15-000444#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001579887","owner_name":"Backenroth Samuel","owner_display_name":"Backenroth Samuel","owner_url":"/insider/0001579887","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":10125.0,"total_display":"10,125.00","total_whole":"10,125","shares_owned_after":6199.0,"shares_owned_after_display":"6,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-06","filed_date":"2015-02-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001173281","name":"NeuBase Therapeutics, Inc.","url":"/issuer/0001173281","role":"Officer (CFO, Treasurer & Secretary)","n_filings":5,"first_seen":"2015-02-10","last_seen":"2020-05-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001579887","retrieved_at":"2026-08-25T04:28:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}